Table 3. . Treatments typical, number of cells injected and route of administration by business/clinic.

Business/clinic	Treatments typical (n)	Cells injected (n)	Route of administration
Business A	Multiple	Not applicable	Transdermal-like patch
Clinic B	1	1.1 million	Injection (method of injection was unspecified)
Clinic C	Unspecified	Up to 500 million	Intravenous injection for orthopedic conditions (route of administration for other conditions was unspecified)
Clinic D	2–3	Unspecified	Injection (method of injection was unspecified)
Clinic E	Unspecified	Unspecified	Intravenous injection for systemic illnesses; intra-articular injections for joint therapy
Clinic F	Unspecified	Unspecified	Injection (method of injection was unspecified)
Clinic G	Unspecified	10–30 million	Intravenous injection
Clinic H	1–2	10 million	Intravenous injection, inhalation